Skip to content

    Incontinence & Overactive Bladder Health Center

    Font Size

    FDA OKs First Overactive Bladder Gel

    Gelnique Is the First and Only Topical Gel for Overactive Bladder
    WebMD Health News
    Reviewed by Louise Chang, MD

    Jan. 28, 2009 -- The FDA has approved Gelnique, the first and only topical gel to treat overactive bladder.

    Watson Pharmaceuticals, which makes Gelnique, announced the approval in a news release.

    Gelnique's active ingredient, oxybutynin, isn't new; it's an antispasmodic agent that's already available in oral tablets and in a patch. But in gel form, that active ingredient doesn't get metabolized by the liver, curbing side effects, according to Watson Pharmaceuticals.

    Watson Pharmaceuticals says the FDA approved Gelnique based on a clinical trial that included 789 patients with overactive bladder. During the 12-week trial, Gelnique trumped a placebo at reducing incontinence episodes and urinary frequency and at increasing urine void volume.

    Gelnique was well tolerated in the clinical trial. Side effects included dry mouth and application site reactions; there were no serious adverse events, Watson Pharmaceuticals notes.

    Gelnique, which is a prescription drug, is applied once daily to the thigh, abdomen, upper arm, or shoulder. Watson Pharmaceuticals expects to make the gel available by prescription in the second quarter of this year.

    Today on WebMD

    womens restroom sign
    Symptoms, causes, and treatments.
    hand over mouth
    Test your urine knowledge.
    man breathing with mouth open
    Is it true that men can do kegels?
    bathroom sign running
    Assess your symptoms.
    woman holding water
    Food That Makes You Gotta Go
    Male Incontinence Slideshow
    Mature woman standing among peers
    Worried in bed
    woman standing in front of restroom sign
    various pills
    sitting in chair